Lawson D H, Henderson A K, McGeachy R R
Postgrad Med J. 1974 Aug;50(586):500-3. doi: 10.1136/pgmj.50.586.500.
This paper presents data on the absorption and disappearance of a new semisynthetic antibiotic—amoxycillin—in patients with pernicious anaemia and those with renal failure. Absorption of this drug is unimpaired in these patients. Adequate serum and urine levels are obtained even in patients with creatinine clearance levels below 10 ml/min. The half-life of this drug is markedly prolonged in patients undergoing regular dialysis therapy, and a single 250 mg dose will provide adequate serum levels for 24 hr, if this is given after dialysis is complete.
本文介绍了一种新型半合成抗生素——阿莫西林在恶性贫血患者和肾衰竭患者体内的吸收及消除情况。这些患者对该药的吸收未受影响。即使肌酐清除率低于10毫升/分钟的患者也能达到足够的血清和尿液水平。在接受定期透析治疗的患者中,该药的半衰期明显延长,如果在透析结束后给予单次250毫克剂量,将能在24小时内维持足够的血清水平。